Neurocrine Biosciences (NBIX) Operating Income (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Operating Income of $331.3 million for Q3 2026, up 38.6% from $239 million a year earlier and up 118.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Neurocrine Biosciences' Operating Income came in at $887.1 million, up 61.2% year-over-year; for FY2025, it was $619.1 million, up 8.5% from FY2024.
- Operating Income has increased for four consecutive years, with a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
- By year, Operating Income came in at $570.5 million in FY2024 (+127.4%), $250.9 million in FY2023 (+0.8%), $249 million in FY2022 (+142.9%) and $102.5 million in FY2021 (-37.1%).
- The Q3 2026 figure ranks as the highest quarterly Operating Income in data going back to Q2 2010.
- Year over year, Operating Income has now increased in each of the last six quarters, with growth averaging 94.9% over the last eight quarters.
- The high point for year-over-year Operating Income in five years was Q1 2026 (growth of 719.5%); the low point was Q1 2022 (a decline of 90.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $151.5 million (Q2 2026), $193.4 million (Q1 2026) and $210.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 331.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 331.30 Mn |
| Jun 30, 2026 | 151.50 Mn |
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 210.90 Mn |
| Sep 30, 2025 | 239.00 Mn |
| Jun 30, 2025 | 145.60 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 142.00 Mn |
| Sep 30, 2024 | 183.80 Mn |
| Jun 30, 2024 | 145.40 Mn |
| Mar 31, 2024 | 99.30 Mn |
| Dec 31, 2023 | 150.30 Mn |
| Sep 30, 2023 | 141.20 Mn |
| Jun 30, 2023 | 73.60 Mn |
| Mar 31, 2023 | -114.20 Mn |
| Dec 31, 2022 | 103.40 Mn |
| Sep 30, 2022 | 87.80 Mn |
| Jun 30, 2022 | 54.70 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | -36.30 Mn |
API Access
Neurocrine Biosciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();